000 01368 a2200361 4500
005 20250516105514.0
264 0 _c20130809
008 201308s 0 0 eng d
022 _a1873-5126
024 7 _a10.1016/j.parkreldis.2012.07.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnston, Tom H
245 0 0 _aRGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study.
_h[electronic resource]
260 _bParkinsonism & related disorders
_cFeb 2013
300 _a260-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aCallithrix
650 0 4 _aDyskinesia, Drug-Induced
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aLevodopa
_xadverse effects
650 0 4 _aParkinsonian Disorders
_xdrug therapy
700 1 _aHuot, Philippe
700 1 _aDamude, Sammie
700 1 _aFox, Susan H
700 1 _aJones, Steven W
700 1 _aRusche, James R
700 1 _aBrotchie, Jonathan M
773 0 _tParkinsonism & related disorders
_gvol. 19
_gno. 2
_gp. 260-4
856 4 0 _uhttps://doi.org/10.1016/j.parkreldis.2012.07.001
_zAvailable from publisher's website
999 _c22033435
_d22033435